Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2009

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Erlotinib

Tarceva (150 mg) is a pill you take once a day -- every day

DRUG

taxotere

Taxotere® (docetaxel) is given intravenously (I.V.) into the vein. Taxotere® chemotherapy treatment takes about one hour, and usually people receive treatments every three weeks.

Trial Locations (22)

13100

Site 12, Aix-en-Provence

13274

Site 06, Marseille

13695

Site 27, Martigues

24019

Site 19, Périgueux

35033

Site 20, Rennes

51092

Site 02, Reims

60021

Site 22, Beauvais

63000

Site 48, Clermont-Ferrand

69655

Site 11, Villefranche-sur-Saône

75012

Site 26, Paris

76031

Site 18, Rouen

76233

Site 17, Rouen

76503

Site 32, Elbeuf

77108

Site 01, Meaux

78157

Site 41, Le Chesnay

78200

Site 25, Mantes-la-Jolie

83300

Site 07, Draguignan

83800

Site 14, Toulon

94010

Site 33, Créteil

08000

Site 30, Charleville-Mézières

05000

Site 04, Gap

Unknown

Site 00, Limoges

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

Chugai Pharma USA

INDUSTRY

lead

Groupe Francais De Pneumo-Cancerologie

OTHER

NCT00418704 - Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter